CE Marked Joint Injection for Knee Pain Relief with Hyaluronic Acid Gel

Name: CE Marked Joint Injection for Knee Pain Relief with Hyaluronic Acid Gel
Brand: Qufu Hi-Tech Group Co., Ltd.
SKU: 1985424301

Shandong, ChinaQufu Hi-Tech Group Co., Ltd.

US$15.00

5-99 Pieces

US$14.00

100-299 Pieces

US$13.00

300-499 Pieces

US$12.00

500+ Pieces

Sample price:US$20.00/piece.Request sample

Product profile

Customization

Available

Supply Type

OEM/ODM

Usage Mode

For external use

Model NO.

5ml

Suitable for

Adult

Form

Gel

Ha Concentration

10-30mg/Ml ( Customizable )

Function

Knee Pain Removal, Osteoarthritis Treatment

Shipping Method

DHL UPS EMS FedEx

Shelf Life

3 Years

Transport Package

One Syringe Per Box

Specification

19X7.5X2.5 cm

Trademark

TOP-Q

Origin

Shandong, China

HS Code

3913900000

Production Capacity

100000pieces/Year

Company profile

Customization from SamplesManagement CertificationProduct CertificationHigh Repeat Buyers Choice

Qufu Hi-Tech Group Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Group CorporationExport Year: 2000-08-01Nearest Port: qingdao, shanghai, shenzhenAverage Response Time: ≤4.50hTerms of Payment: T/T, PayPal, Western Union, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP, DAP

AI-Powered supplier vetting

SummaryThe supplier presents itself as a hyaluronic-acid product manufacturer with more than 26 years of experience, GMP production facilities, a technical team, and products including dermal fillers, mesotherapy products, skin boosters, thread lifts, and sodium hyaluronate gels. It holds CE and RoHS product certifications and reports 90% export sales, 12 years of export experience, and self-operated import/export rights. It supports sample-based customization and reported new products within the past year, but does not offer ODM, 3D software design, SDKs, or OEM services for popular brands. Service infrastructure is limited: no in-stock capacity, overseas warehouse, overseas showroom, overseas agents, or stated overseas-service countries. Lead times are within 15 working days in both peak and off-season. Financial records are indicated for 2023–2025, but their contents are not provided. Customer-specific cases are not identified.

Supplier typeThe supplier describes itself as a professional factory and manufacturer of hyaluronic-acid-based products, with over 26 years of experience and a GMP production plant. Its listed product range is concentrated in dermal fillers and related injectable or gel products.

CertificationsThe supplier reports CE and RoHS product compliance certifications and describes a GMP production plant with a testing system. However, the management-system certification is recorded only as “Others,” without a named standard or certificate details.

After-Sales capabilityThe supplier has no overseas warehouse, showroom, agent, branch, or in-stock service capacity, and it lists zero countries where overseas services are offered. It has participated in the Dubai Derma Exhibition and accepts multiple quotation and payment terms, but the evidence does not establish a developed after-sales network.

R&D capabilityThe supplier reports a mature scientific research section, a professional technical team, and new products within the past year. Nevertheless, it has no available SDK, no ODM service, no 3D software design service, and no OEM service for popular brands, limiting the demonstrated scope of innovation support.

Production capacityEvidence supports established manufacturing operations: a GMP production plant, a complete testing system, 21–50 total staff experience, 90% export sales, 12 years of export experience, and stated lead times within 15 working days in both peak and off-season. Quality-control resources appear limited to one inspector, and finished-product inspection has instructions but no written records.

Customization capabilityThe supplier offers customization from samples, demonstrating a defined sample-based customization capability. It does not provide ODM services or 3D software design services, so customization appears limited to adapting supplied samples rather than broader original development.